Mapp Biopharmaceutical
Press Inquiries

Mapp Biopharmaceutical, Inc.

We develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.

Press Releases

More Press Releases
Publications

Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal Antibody

Dafna Abelson, Jennifer Barajas, Lauren Stuart, Do Kim, Arumugapradeep Marimuthu, Chris Hu, Brent Yamamoto, Eric Ailor, Kevin J Whaley, Hong Vu, Krystle N Agans, Viktoriya Borisevich, Daniel J Deer, Natalie S Dobias, Courtney Woolsey, Abhishek N Prasad, Jennifer E Peel, William S Lawrence, Robert W Cross, Thomas W Geisbert, Karla A Fenton, Larry Zeitlin

J infect Dis. 2023 Nov13;228(Supplement_7):S701-S711.doi:  10.1093/infdis/jiad278.

Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody

Larry Zeitlin, Robert W Cross, Joan B Geisbert, Viktoriya Borisevich, Krystle N Agans, Abhishek N Prasad, Sven Enterlein, M Javad Aman, Zachary A Bornholdt, Miles B Brennan, Lioudmila Campbell, Do Kim, Neil Mlakar, Crystal L Moyer, Michael H Pauly, William Shestowsky, Kevin Whaley, Karla A Fenton, Thomas W Geisbert

Proc Natl Acad Sci USA. 2021 Mar 16;118(11):e2023332118. doi: 10.1073/pnas.2023332118.

VIEW MORE PUBLICATIONS